Giving in Action

Coming Together to Support a Clinical Trial Exploring COVID-19

At present there is no standard antiviral therapy approved by the Food and Drug Administration (FDA) for the treatment of people with COVID-19 (coronavirus). To address this, researchers at Rutgers Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center, are exploring whether an antibiotic combined with a malaria treatment drug, is better than the latter drug alone for treatment of patients with COVID-19.

 

The clinical trial, which is not limited to cancer patients, has received support from a number of entities:

  • Marken/UPS Express Critical